- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- S-4/A Registration of securities issued in business combination transactions
- 5.1 EX-5.1
- 8.1 EX-8.1
- 8.2 EX-8.2
- 23.1 EX-23.1
- 23.2 EX-23.2
- 23.3 EX-23.3
- 99.3 EX-99.3
- 99.4 EX-99.4
- 99.5 EX-99.5
- 99.6 EX-99.6
- 99.8 EX-99.8
- 99.9 EX-99.9
- 99.10 EX-99.10
- 99.11 EX-99.11
- 99.12 EX-99.12
- 99.13 EX-99.13
- 99.14 EX-99.14
- 99.15 EX-99.15
- 99.16 EX-99.16
- 99.17 EX-99.17
- 99.18 EX-99.18
- 99.19 EX-99.19
Exhibit 99.3
CONSENT OF J.P. MORGAN SECURITIES LLC
We hereby consent to (i) the use of our opinion letter dated June 15, 2016 to the Board of Directors of AmSurg Corp. (the “Company”) included in Annex B to the Joint Proxy Statement-Prospectus relating to the proposed merger of the Company and Envision Healthcare Holdings, Inc., and (ii) the references to such opinion in such Joint Proxy Statement-Prospectus. In giving such consent, we do not admit that we come within the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended, or the rules and regulations of the Securities and Exchange Commission thereunder, nor do we hereby admit that we are experts with respect to any part of such Registration Statement within the meaning of the term “experts” as used in the Securities Act of 1933, as amended, or the rules and regulations of the Securities and Exchange Commission thereunder.
J.P. MORGAN SECURITIES LLC | ||
By: | /s/ Tom Monaghan | |
Name: Tom Monaghan Title: Managing Director |
October 7, 2016